|
|
|
By Tom von Gunden, chief editor, Drug Delivery Leader | In this article, Chief Editor Tom von Gunden considers the need for and benefit of conducting AI-based research into regulatory precedents for drug delivery submissions and approvals. He consults combination products consultant Doug Mead on best practices in bolstering regulatory intelligence and regulatory approval success by way of advanced search methods. | |
|
|
Killing Cancer With Intratumoral Injections | By Lew Bender, Intensity Therapeutics, Inc. | Intratumoral injection bypasses the tumor’s physical defenses entirely, killing cancer cells and creating a personalized immune response that destroys solid tumors. |
|
|
|
|
| Reshaping Production Scale For Sterile Injectables | E-Book | Kindeva | Bridgeton's sterile site unites advanced filling tech, integrated quality, and scalable capacity to streamline complex injectables, reduce risk, and support efficient progress to commercial supply. |
|
|
| Leveraging Nanotechnology For Sustained Release | Article | Nanoform | Advances in sustained-release drug delivery could improve efficiency and consistency in drug release, manifesting real-life advantages for patients in the form of enhanced accessibility and compliance. |
|
|
| Automated Process Development Accelerates LNP Production | Application Note | MilliporeSigma | Manual LNP formulation introduces process variability that threatens particle quality and yield. As programs scale toward clinical production, maintaining strict control over CQAs becomes essential. |
|
|
|
|
|
.png){kind=logo}
